GLOBUS MEDICAL INC - A (GMED) Stock Cash Flow
NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 185.56M | 102.98M | 122.87M | 190.20M | 149.20M | |||
| Depreciation Amortization | 264.84M | 254.02M | 144.73M | 68.30M | 69.90M | |||
| Income Taxes - Deferred | -80.30M | -125.90M | -57.79M | -22.20M | -17.60M | |||
| Change In Working Capital | -45.23M | -97.55M | -116.60M | -105.30M | -17.30M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 163.74M | 158.51M | 100.59M | 77.80M | 45.00M | |||
| Other non cash items | 320.69M | 387.09M | 150.28M | 47.50M | 92.10M | |||
| OPERATING CASH FLOW | 645.55M | 520.64M | 243.50M | 178.50M | 276.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -127.96M | -115.43M | -78.27M | -74.00M | -56.90M | |||
| Other Investing Activity | 129.88M | -60.62M | 381.24M | -36.30M | -319.00M | |||
| INVESTING CASH FLOW | 1.92M | -176.05M | 302.97M | -110.40M | -375.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | -74.67M | 24.65M | -213.16M | -102.80M | 63.50M | |||
| Other Financing Activity | -22.71M | -52.35M | -18.66M | -7.20M | -9.30M | |||
| FINANCING CASH FLOW | -547.37M | -27.70M | -231.82M | -110.00M | 54.10M | |||
| Exchange Rate Effect | 7.11M | 255.00K | 2.18M | -700.00K | -800.00K | |||
| CHANGE IN CASH | 107.20M | 317.15M | 316.83M | -42.60M | -46.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 645.55M | 520.64M | 243.50M | 178.50M | 276.30M | |||
| Capital Expenditure | -127.96M | -115.43M | -78.27M | -74.00M | -56.90M | |||
| FREE CASH FLOW | 517.59M | 405.21M | 165.22M | 104.50M | 219.40M | |||
All data in USD